Hydroxypropyl-β-CD (HPβCD) is known to have efficacy for NPC disease and rescue the cholesterol accumulation defect in human cells with NPC1 or NPC2 mutations [20,23,24,25]. The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.